<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Type I Diabetes - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "‚Ü≥ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Type I Diabetes</span>
        </nav>

        <header class="page-header">
            <h1>Type I Diabetes</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Metabolic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0005147" target="_blank">
                        MONDO:0005147
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Autoimmune Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Diabetes Mellitus</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">11</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">18</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">9</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">endocrine system disorder</span>
                    
                    <span class="tag tag-classification">diabetes mellitus</span>
                    
                    <span class="tag tag-classification">autoimmune disease</span>
                    
                </div>
            </div>
            
            
            
            
            
            
        </div>
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">11</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Genetic Susceptibility</div>
                
                <div class="item-desc">Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility genes (INS) increase the risk of developing Type I Diabetes.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        HLA-DQ2
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        HLA-DQ8
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        INS
                        
                        <a href="https://bioregistry.io/hgnc:6081" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11554771" target="_blank">PMID:11554771</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The HLA-DQ genes are the primary susceptibility genes within this region, although other genes may also contribute. The IDDM2 locus maps to a variable number of tandem repeats in the insulin gene region on chromosome 11."</div>
                
                
                <div class="evidence-explanation">The provided literature confirms that HLA-DQ and INS genes contribute to the genetic susceptibility to Type 1 Diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31331105" target="_blank">PMID:31331105</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HLA DQA1*05 and DQB1*02 alleles encoding the DQ2.5 molecule and HLA DQA1*03 and DQB1*03 alleles encoding DQ8 molecules are strongly associated with celiac disease (CD) and type 1 diabetes (T1D), two common autoimmune diseases (AD)"</div>
                
                
                <div class="evidence-explanation">The presence of HLA-DQ2 and HLA-DQ8 variants contributing to the genetic susceptibility of Type I Diabetes is supported.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3309680" target="_blank">PMID:3309680</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Over half of the inherited predisposition to insulin-dependent diabetes mellitus maps to the region of chromosome 6 that contains the highly polymorphic HLA class II genes which determine immune responsiveness."</div>
                
                
                <div class="evidence-explanation">HLA class II genes, including HLA-DQ, play significant roles in the predisposition to Type I Diabetes.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Environmental Triggers</div>
                
                <div class="item-desc">Viral infections or early dietary factors (cow&#39;s milk, gluten) may trigger the autoimmune response in genetically susceptible individuals.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10522815" target="_blank">PMID:10522815</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Various exogenous triggers, such as certain dietary factors and viruses, are thought to induce the autoimmune process leading in some individuals to extensive beta-cell destruction and ultimately to the clinical manifestation of type 1 diabetes."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by mentioning that dietary factors and viruses can trigger the autoimmune process in genetically susceptible individuals.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21162649" target="_blank">PMID:21162649</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The ability to induce strong cellular immune responses and to cause inflammation in the target organ makes viral infections prime candidates for the initiation of islet autoreactivity."</div>
                
                
                <div class="evidence-explanation">The reference supports the role of viral infections in triggering autoimmune responses leading to type 1 diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18357774" target="_blank">PMID:18357774</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most often cited environmental agents implicated as initiators of T1D are the human enteroviruses, in particular the group B coxsackieviruses (CVB)."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by identifying enteroviruses as environmental triggers for type 1 diabetes.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Interferon-Driven Beta Cell Response</div>
                
                <div class="item-desc">Type I and type II interferons upregulate antigen presentation and chemokine production in beta cells while downregulating oxidative phosphorylation, increasing immunogenicity and metabolic stress.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        type B pancreatic cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000169" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        type I interferon signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0060337" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        antigen processing and presentation of peptide antigen via MHC class I
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0002474" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        chemokine production
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0032602" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        oxidative phosphorylation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006119" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üì DECREASED
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38409439" target="_blank">PMID:38409439</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"IFN-Œ± and IFN-Œ≥ had a greater impact on the beta cell transcriptome when compared with IL-1Œ≤ and TNF-Œ±. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes."</div>
                
                
                <div class="evidence-explanation">This study identifies interferons as key drivers of beta cell inflammatory responses, upregulating antigen presentation and chemokine production.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Autoimmune Destruction of Beta Cells</div>
                
                <div class="item-desc">The immune system mistakenly targets and destroys insulin-producing beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        type B pancreatic cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000169" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        CD8-positive, alpha-beta cytotoxic T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000794" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        CD4-positive, alpha-beta T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000624" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        regulatory T cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000815" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        B cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000236" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        dendritic cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000451" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        T cell mediated cytotoxicity
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0001913" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        autoantibody production
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚ö† ABNORMAL
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        cytokine-mediated signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019221" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        pancreatic islet
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000006" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (8 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12185667" target="_blank">PMID:12185667</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease that results in the destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans."</div>
                
                
                <div class="evidence-explanation">While T-cell mediated cytotoxicity is mentioned, there is no reference to autoantibody production.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23774118" target="_blank">PMID:23774118</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Phenotypes of infiltrating cells around and/or into islets were mainly dendritic cells, macrophages and CD8+ T cells."</div>
                
                
                <div class="evidence-explanation">Supports T cell-mediated cytotoxicity but does not discuss autoantibody production.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27659143" target="_blank">PMID:27659143</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The autoimmune destruction of the pancreatic islet beta cells is due to a targeted lymphocyte attack."</div>
                
                
                <div class="evidence-explanation">Supports T cell-mediated cytotoxicity but does not mention autoantibody production.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 5 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Insulin Deficiency</div>
                
                <div class="item-desc">Loss of beta cells leads to a deficiency of insulin, a hormone required for glucose uptake.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35254878" target="_blank">PMID:35254878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic beta cells stop producing insulin, typically due to autoimmune destruction."</div>
                
                
                <div class="evidence-explanation">This confirms that the loss of beta cells leads to a deficiency of insulin in Type 1 diabetes, as stated in the provided statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21281836" target="_blank">PMID:21281836</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Insulin resistance and defective glucose sensing at the beta-cell are the central pathophysiologic determinants that together cause hyperglycemia."</div>
                
                
                <div class="evidence-explanation">Although it primarily discusses prediabetes and Type 2 diabetes, the excerpt supports the idea that beta-cell issues lead to hyperglycemia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2006409" target="_blank">PMID:2006409</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Glucose uptake into pancreatic beta cells by means of the glucose transporter GLUT-2, which has a high Michaelis constant, is essential for the normal insulin secretory response to hyperglycemia."</div>
                
                
                <div class="evidence-explanation">This indicates the importance of beta cells in glucose regulation and the resulting hyperglycemia when their function is impaired.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hyperglycemia</div>
                
                <div class="item-desc">Lack of insulin results in high blood glucose levels, as glucose cannot be efficiently taken up by cells.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33970586" target="_blank">PMID:33970586</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 diabetes is defined as a state of hyperglycemia due to insulin deficiency caused by autoimmune pancreatic beta-cell destruction."</div>
                
                
                <div class="evidence-explanation">The abstract from PMID:33970586 confirms that type 1 diabetes is characterized by hyperglycemia due to insulin deficiency, which supports the statement regarding elevated blood glucose and related downstream effects.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37921158" target="_blank">PMID:37921158</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HbA1c offers a trustworthy indicator of chronic hyperglycemia and strongly correlates with the likelihood of long-term consequences from diabetes."</div>
                
                
                <div class="evidence-explanation">Although this reference supports the relationship between elevated HbA1c and hyperglycemia, it does not specifically address all the downstream effects such as Glucosuria, Polyuria, Polydipsia, and Diabetic Ketoacidosis (DKA).</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21281836" target="_blank">PMID:21281836</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The phenotype of prediabetes includes dyslipidemia and higher arterial blood pressure."</div>
                
                
                <div class="evidence-explanation">This study does not specifically address the pathophysiology of type 1 diabetes or the particular assays and downstream effects mentioned in the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Impaired Glucose Utilization</div>
                
                <div class="item-desc">Without insulin, cells are unable to utilize glucose for energy production, leading to cellular energy deficiency.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12477252" target="_blank">PMID:12477252</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 or insulin-dependent diabetes mellitus is caused by autoimmune attack and selective destruction of the pancreatic beta cells."</div>
                
                
                <div class="evidence-explanation">The lack of insulin in type 1 diabetes mellitus leads to impaired glucose utilization as described in the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15137354" target="_blank">PMID:15137354</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The following article reviews the basic pathophysiology of both type 1 diabetes mellitus and type 2 diabetes mellitus as we understand it today."</div>
                
                
                <div class="evidence-explanation">This article explains that in diabetes, particularly type 1, the lack of insulin results in impaired glucose utilization, leading to characteristic symptoms like weight loss and fatigue.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">ER Stress and Unfolded Protein Response</div>
                
                <div class="item-desc">Inflammatory cytokines induce endoplasmic reticulum stress in beta cells, activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        type B pancreatic cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000169" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        endoplasmic reticulum unfolded protein response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030968" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        apoptotic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006915" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38409439" target="_blank">PMID:38409439</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"IFN-Œ± and IFN-Œ≥ had a greater impact on the beta cell transcriptome when compared with IL-1Œ≤ and TNF-Œ±. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes."</div>
                
                
                <div class="evidence-explanation">This study shows interferons drive beta cell stress responses including ER stress pathways that contribute to beta cell dysfunction and death.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Increased Lipolysis</div>
                
                <div class="item-desc">Insulin deficiency also leads to increased breakdown of fat (lipolysis) for energy, resulting in the production of ketones.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6409465" target="_blank">PMID:6409465</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Insulin deficiency results in increased rates of lipolysis and provides increased substrate (free fatty acids) for ketogenesis."</div>
                
                
                <div class="evidence-explanation">The article explains that insulin deficiency leads to increased lipolysis, which eventually results in the production of ketone bodies. This supports the statement&#39;s claim about the pathophysiology involving lipolysis and ketone production in Type I Diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15137354" target="_blank">PMID:15137354</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis."</div>
                
                
                <div class="evidence-explanation">The article suggests that DKA is a critical concern in Type I Diabetes due to insufficient insulin, which is aligned with the statement indicating the downstream effect of heightened lipolysis and ketone production.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34922394" target="_blank">PMID:34922394</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the involvement of B:9-23rPep-specific IFN-gamma-related immunoreactivity in the pathophysiology of some unprovoked A-beta+ KPD."</div>
                
                
                <div class="evidence-explanation">Although the study highlights immune responses related to ketosis-prone Type 2 Diabetes, it indirectly supports the notion that immune-mediated processes can contribute to ketosis and DKA.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Chronic Complications</div>
                
                <div class="item-desc">Persistent hyperglycemia over time can lead to damage in various tissues and organs.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31346658" target="_blank">PMID:31346658</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy."</div>
                
                
                <div class="evidence-explanation">The literature indicates that hyperglycemia is a significant factor in the pathophysiology of diabetic complications including kidney disease (nephropathy), retinopathy, and neuropathy, thereby supporting the claim.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34407376" target="_blank">PMID:34407376</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hyperglycemia is the common denominator for most of the chronic diabetic vascular complications, which represent the main cause of life reduction in T1D patients."</div>
                
                
                <div class="evidence-explanation">This reference indicates that hyperglycemia underlies various chronic vascular complications in type 1 diabetes, thus supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3528691" target="_blank">PMID:3528691</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The remaining 15 to 20% of patients have insulin-dependent diabetes mellitus, a disorder caused by the destruction of insulin-producing endocrine cells within the pancreas and currently considered to be the result of an autoimmune process. During the course of both types of diabetes mellitus,..."</div>
                
                
                <div class="evidence-explanation">The study confirms that type 1 diabetes, which involves insulin-dependent diabetes mellitus, results in long-term complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Diabetic Ketoacidosis (DKA)</div>
                
                <div class="item-desc">Life-threatening metabolic emergency from insulin deficiency</div>
                
                
                
                
                
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Retinopathy[&#34;Retinopathy&#34;]
    Chronic_Complications[&#34;Chronic Complications&#34;]
    Polyuria[&#34;Polyuria&#34;]
    Environmental_Triggers[&#34;Environmental Triggers&#34;]
    Polydipsia[&#34;Polydipsia&#34;]
    Weight_Loss[&#34;Weight Loss&#34;]
    Vomiting[&#34;Vomiting&#34;]
    Autoimmune_Destruction_of_Beta_Cells[&#34;Autoimmune Destruction of Beta Cells&#34;]
    Confusion[&#34;Confusion&#34;]
    Neuropathy[&#34;Neuropathy&#34;]
    Nephropathy[&#34;Nephropathy&#34;]
    Abdominal_Pain[&#34;Abdominal Pain&#34;]
    Increased_Lipolysis[&#34;Increased Lipolysis&#34;]
    Cardiovascular_Disease[&#34;Cardiovascular Disease&#34;]
    Impaired_Glucose_Utilization[&#34;Impaired Glucose Utilization&#34;]
    Rapid_Breathing[&#34;Rapid Breathing&#34;]
    Diabetic_Ketoacidosis_DKA[&#34;Diabetic Ketoacidosis (DKA)&#34;]
    Insulin_Deficiency[&#34;Insulin Deficiency&#34;]
    Interferon_Driven_Beta_Cell_Response[&#34;Interferon-Driven Beta Cell Response&#34;]
    Hyperglycemia[&#34;Hyperglycemia&#34;]
    Fatigue[&#34;Fatigue&#34;]
    ER_Stress_and_Unfolded_Protein_Response[&#34;ER Stress and Unfolded Protein Response&#34;]
    Glucosuria[&#34;Glucosuria&#34;]
    Diabetic_Ketoacidosis[&#34;Diabetic Ketoacidosis&#34;]
    Genetic_Susceptibility[&#34;Genetic Susceptibility&#34;]

    Genetic_Susceptibility --&gt; Autoimmune_Destruction_of_Beta_Cells
    Environmental_Triggers --&gt; Autoimmune_Destruction_of_Beta_Cells
    Interferon_Driven_Beta_Cell_Response --&gt; Autoimmune_Destruction_of_Beta_Cells
    Autoimmune_Destruction_of_Beta_Cells --&gt; Insulin_Deficiency
    Insulin_Deficiency --&gt; Hyperglycemia
    Insulin_Deficiency --&gt; Impaired_Glucose_Utilization
    Insulin_Deficiency --&gt; Increased_Lipolysis
    Hyperglycemia --&gt; Glucosuria
    Hyperglycemia --&gt; Polyuria
    Hyperglycemia --&gt; Polydipsia
    Hyperglycemia --&gt; Diabetic_Ketoacidosis_DKA
    Impaired_Glucose_Utilization --&gt; Weight_Loss
    Impaired_Glucose_Utilization --&gt; Fatigue
    ER_Stress_and_Unfolded_Protein_Response --&gt; Autoimmune_Destruction_of_Beta_Cells
    Increased_Lipolysis --&gt; Diabetic_Ketoacidosis_DKA
    Chronic_Complications --&gt; Retinopathy
    Chronic_Complications --&gt; Neuropathy
    Chronic_Complications --&gt; Nephropathy
    Chronic_Complications --&gt; Cardiovascular_Disease
    Hyperglycemia --&gt; Diabetic_Ketoacidosis
    Diabetic_Ketoacidosis --&gt; Abdominal_Pain
    Diabetic_Ketoacidosis --&gt; Vomiting
    Diabetic_Ketoacidosis --&gt; Rapid_Breathing
    Diabetic_Ketoacidosis --&gt; Confusion

    style Retinopathy fill:#fef3c7
    style Chronic_Complications fill:#dbeafe
    style Polyuria fill:#fef3c7
    style Environmental_Triggers fill:#dbeafe
    style Polydipsia fill:#fef3c7
    style Weight_Loss fill:#fef3c7
    style Vomiting fill:#fef3c7
    style Autoimmune_Destruction_of_Beta_Cells fill:#dbeafe
    style Confusion fill:#fef3c7
    style Neuropathy fill:#fef3c7
    style Nephropathy fill:#fef3c7
    style Abdominal_Pain fill:#fef3c7
    style Increased_Lipolysis fill:#dbeafe
    style Cardiovascular_Disease fill:#fef3c7
    style Impaired_Glucose_Utilization fill:#dbeafe
    style Rapid_Breathing fill:#fef3c7
    style Diabetic_Ketoacidosis_DKA fill:#dbeafe
    style Insulin_Deficiency fill:#dbeafe
    style Interferon_Driven_Beta_Cell_Response fill:#dbeafe
    style Hyperglycemia fill:#fef3c7
    style Fatigue fill:#fef3c7
    style ER_Stress_and_Unfolded_Protein_Response fill:#dbeafe
    style Glucosuria fill:#fef3c7
    style Diabetic_Ketoacidosis fill:#fef3c7
    style Genetic_Susceptibility fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">18</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Digestive<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Endocrine<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Eye<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Genitourinary<span class="pill-count">(3)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Metabolism<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-7">Nervous System<span class="pill-count">(3)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-8">Respiratory<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-9">Constitutional<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-10">Growth<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-11">Other<span class="pill-count">(3)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Cardiovascular Disease
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001626" target="_blank">
                                Abnormality of the cardiovascular system
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001626)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Vomiting
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002013" target="_blank">
                                Vomiting
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002013)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Endocrine
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Diabetic Ketoacidosis
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001953" target="_blank">
                                Diabetic ketoacidosis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001953)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Life-threatening complication of insulin deficiency</div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Abdominal Pain</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Vomiting</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Rapid Breathing</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Confusion</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12474677" target="_blank">PMID:12474677</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diabetic ketoacidosis is an emergency medical condition that can be life-threatening if not treated properly. Diabetic ketoacidosis occurs most often in patients with type 1 diabetes (formerly called insulin-dependent diabetes mellitus); however, its occurrence in patients with type 2 diabetes..."</div>
                
                
                <div class="evidence-explanation">The literature supports that diabetic ketoacidosis is a life-threatening complication of type 1 diabetes and mentions symptoms such as abdominal pain and vomiting. However, it does not specify the frequency as &#39;occasional&#39;.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17627511" target="_blank">PMID:17627511</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A small group of patients affected by type 1 diabetes mellitus is characterized by a severe instability of glycemic values with frequent and unpredictable hypoglycemic and/or ketoacidosis episodes which cannot be explained by errors of patients or diabetologists."</div>
                
                
                <div class="evidence-explanation">This reference supports the occurrence of diabetic ketoacidosis in type 1 diabetes and mentions its life-threatening nature but does not confirm the frequency as &#39;occasional&#39;.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15137354" target="_blank">PMID:15137354</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis, hyperglycemic hyperosmolar nonketotic coma (or state), and severe hypoglycemia."</div>
                
                
                <div class="evidence-explanation">The reference confirms that diabetic ketoacidosis is a life-threatening complication of type 1 diabetes and includes symptoms like confusion and rapid breathing but does not specify the frequency as &#39;occasional&#39;.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Retinopathy
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000488" target="_blank">
                                Retinopathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000488)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Genitourinary
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Polyuria
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000103" target="_blank">
                                Polyuria
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000103)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Caused by osmotic diuresis from hyperglycemia</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35254878" target="_blank">PMID:35254878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Symptoms include polyuria, polydipsia, and weight loss."</div>
                
                
                <div class="evidence-explanation">This reference confirms that polyuria is a frequent symptom of Type I Diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2923250" target="_blank">PMID:2923250</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Poorly controlled insulin-dependent diabetes mellitus is associated with considerable elevations of plasma vasopressin concentrations, although well-controlled diabetics have normal osmoregulated thirst and vasopressin release."</div>
                
                
                <div class="evidence-explanation">This reference discusses the association of poorly controlled insulin-dependent diabetes mellitus (Type I Diabetes) with symptoms such as polyuria.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Glucosuria
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0003076" target="_blank">
                                Glycosuria
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0003076)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Nephropathy
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000112" target="_blank">
                                Nephropathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000112)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Metabolism
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hyperglycemia
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0003074" target="_blank">
                                Hyperglycemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0003074)</span>
                        </span>
                        
                    </div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Diabetic Ketoacidosis</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38272591" target="_blank">PMID:38272591</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy."</div>
                
                
                <div class="evidence-explanation">This source supports the statement by associating Type I Diabetes with hyperglycemia and chronic complications such as retinopathy and neuropathy, as well as acute complications like diabetic ketoacidosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28544185" target="_blank">PMID:28544185</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Participation in prospective follow-up studies reduces the frequency of DKA in children at diagnosis of T1D, but genetic screening alone does not decrease DKA risk."</div>
                
                
                <div class="evidence-explanation">This source supports the statement by confirming that Diabetic Ketoacidosis (DKA) is a frequent acute complication in Type 1 Diabetes at the time of diagnosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34362315" target="_blank">PMID:34362315</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Although SH was usually benign and long-term treatment was superfluous, it might be the first sign of insulinopenic status such as type 1 DM (T1DM)"</div>
                
                
                <div class="evidence-explanation">This source supports the statement by describing stress hyperglycemia as a potential initial presentation of Type 1 Diabetes, thereby confirming hyperglycemia as a very frequent occurrence.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-7">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Polydipsia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001959" target="_blank">
                                Polydipsia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001959)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Excessive thirst due to dehydration from polyuria</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35254878" target="_blank">PMID:35254878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Symptoms include polyuria, polydipsia, and weight loss."</div>
                
                
                <div class="evidence-explanation">The reference clearly states that polydipsia is a symptom of Type 1 Diabetes Mellitus, supporting the statement that it is a frequent systemic occurrence.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Neuropathy
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0009830" target="_blank">
                                Peripheral neuropathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0009830)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Confusion
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001289" target="_blank">
                                Confusion
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001289)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-8">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Respiratory
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Rapid Breathing
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002789" target="_blank">
                                Tachypnea
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002789)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-9">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Constitutional
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Fatigue
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank">
                                Fatigue
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012378)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Abdominal Pain
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002027" target="_blank">
                                Abdominal pain
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002027)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-10">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Growth
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Weight Loss
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001824" target="_blank">
                                Weight loss
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001824)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Due to inability to utilize glucose for energy</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23075321" target="_blank">PMID:23075321</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Immune-mediated (auto-immune) Type 1 diabetes mellitus is not a homogenous entity, but nonetheless has distinctive characteristics. In children, it may present with classical insulin deficiency and ketoacidosis at disease onset, whereas autoimmune diabetes in adults may not always be insulin dependent."</div>
                
                
                <div class="evidence-explanation">The source does indicate that Type 1 diabetes has varied presentations, including insulin deficiency and potentially weight loss due to failure to utilize glucose. However, the excerpt does not specifically mention weight loss as a frequent phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12949265" target="_blank">PMID:12949265</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">The provided literature does not directly discuss weight loss as a frequent systemic phenotype of Type 1 diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11508279" target="_blank">PMID:11508279</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">This reference discusses the Accelerator Hypothesis and weight gain in diabetes but does not address weight loss in Type 1 diabetes.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-11">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Diabetic Retinopathy
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Leading cause of blindness, due to chronic hyperglycemia</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24864506" target="_blank">PMID:24864506</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diabetes mellitus (DM), due to its epidemic prevalence and high occurrence of associated disability, is now one of the priority medical and social problems. Incapacitating manifestations of diabetes include visual impairment. Thus, diabetic retinopathy (DR), a late nonspecific vascular..."</div>
                
                
                <div class="evidence-explanation">The literature mentions diabetic retinopathy as a leading cause of blindness in the working-age population but does not provide specific information on its frequency in Type I Diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37469057" target="_blank">PMID:37469057</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The commonest morbidity was cataract12,607(28.8%), followed by refractive errors 8,508(19.5%), vision-threatening diabetic retinopathy 2,553(5.83%) and suspected glaucoma 1,211(2.76%)."</div>
                
                
                <div class="evidence-explanation">The study provides data on the prevalence of diabetic retinopathy in a diabetic population but does not specify it as occasional in Type I Diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38272591" target="_blank">PMID:38272591</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy."</div>
                
                
                <div class="evidence-explanation">The article mentions retinopathy as a complication of Type 1 diabetes but does not specify its frequency as occasional.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Diabetic Neuropathy
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Nerve damage from chronic hyperglycemia</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28159476" target="_blank">PMID:28159476</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Aggressive glucose control can result in treatment induced neuropathy of diabetes (TIND) if glycemic control is achieved too quickly."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that aggressive glycemic control can lead to diabetic neuropathy, which is a neurologic complication of Type I Diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33071962" target="_blank">PMID:33071962</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Glycemic variability (GV) may attribute to the pathogenesis of diabetic neuropathy."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement that diabetic neuropathy is a neurologic complication associated with glycemic variability, which can be linked to chronic hyperglycemia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33715053" target="_blank">PMID:33715053</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Emerging evidence suggests that hyperglycemia and time in range may be more important for brain development than episodes of hypoglycemia."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by highlighting the role of hyperglycemia in neurocognitive complications, which can be related to diabetic neuropathy in Type I Diabetes.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Diabetic Nephropathy
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Kidney damage from chronic hyperglycemia</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23290727" target="_blank">PMID:23290727</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Renal failure in type 2 diabetes has been termed &#39;a medical catastrophe of worldwide dimension&#39;."</div>
                
                
                <div class="evidence-explanation">This study primarily discusses renal failure in type 2 diabetes, not type 1 diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27903991" target="_blank">PMID:27903991</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diabetic nephropathy (DN) is a serious complication of diabetes mellitus, and its prevalence has been increasing in developed countries."</div>
                
                
                <div class="evidence-explanation">The study mentions diabetic nephropathy as a serious complication of diabetes mellitus in general, without specifying the frequency in type 1 diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1490695" target="_blank">PMID:1490695</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most serious complication of diabetes mellitus is clinical nephropathy."</div>
                
                
                <div class="evidence-explanation">The study highlights nephropathy as a serious complication of diabetes mellitus but does not specify its frequency in type 1 diabetes.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">9</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HLA-DQ2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22184118" target="_blank">PMID:22184118</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D)."</div>
                
                
                <div class="evidence-explanation">This study identifies HLA-DQ2 as a strongly predisposing haplotype for type 1 diabetes susceptibility.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HLA-DQ8
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22184118" target="_blank">PMID:22184118</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D)."</div>
                
                
                <div class="evidence-explanation">This statement specifically mentions HLA-DQ8 as a strong predisposing haplotype for type 1 diabetes, supporting the association with susceptibility.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26492519" target="_blank">PMID:26492519</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The DR3-DQ2/DR4-DQ8 genotype conferred the highest detected risk for T1D."</div>
                
                
                <div class="evidence-explanation">This study identifies the DR4-DQ8 genotype as highly associated with a risk for developing type 1 diabetes, thus supporting the genetic susceptibility.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34946827" target="_blank">PMID:34946827</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The combination of HLA-DQA1*03:01 and DQB1*03:02 alleles (summarized as &#39;HLA-DQ8&#39;) is reported to be among the two most prevalent HLA class II haplotypes in Caucasian type 1 diabetes patients."</div>
                
                
                <div class="evidence-explanation">This reference confirms that HLA-DQ8 is one of the most prevalent haplotypes among type 1 diabetes patients in the studied population, supporting its association with susceptibility.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    INS
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15529622" target="_blank">PMID:15529622</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Our results indicate an exceptionally strong association of the class I INS-VNTR alleles with T1DM for the Romanian population."</div>
                
                
                <div class="evidence-explanation">The study presents evidence of a strong association between INS-VNTR alleles of the insulin gene and susceptibility to type 1 diabetes in the Romanian population.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8934932" target="_blank">PMID:8934932</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Genetic susceptibility predominantly results from specific alleles in the HLA complex and insulin gene region."</div>
                
                
                <div class="evidence-explanation">This paper states that genetic susceptibility to insulin-dependent diabetes mellitus predominantly results from specific alleles, including those in the insulin gene region.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11845220" target="_blank">PMID:11845220</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"However, only within the past decade has it been possible to systematically attempt to identify the genes that increase susceptibility to this disorder using linkage and association analysis of genetic markers distributed across the genome."</div>
                
                
                <div class="evidence-explanation">This study discusses the identification of susceptibility genes for type 1 diabetes, including the insulin gene.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PTPN22
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15734872" target="_blank">PMID:15734872</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The homozygous genotype for the T allele encoding the 620W residue is associated with an increased risk for developing type 1 diabetes"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that the PTPN22 R620W polymorphism confers significant genetic susceptibility to type 1 diabetes in Caucasian populations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    IL2RA
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22461703" target="_blank">PMID:22461703</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"CD4(+)CD25(+) regulatory T cells (Tregs) from individuals with a range of human autoimmune diseases, including type 1 diabetes, are deficient in their ability to control autologous proinflammatory responses"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that IL2RA variants associated with type 1 diabetes lead to diminished IL-2 responsiveness and impaired regulatory T cell function.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CTLA4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9353155" target="_blank">PMID:9353155</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the presence of a G-containing CTLA-4 genotype confers a moderate but significant RR for IDDM that is independent of age and genetic or immune disease markers"</div>
                
                
                <div class="evidence-explanation">This study demonstrates that CTLA4 gene polymorphisms confer susceptibility to type 1 diabetes independent of other genetic and immune markers.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TYK2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    IFIH1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    BACH2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Insulin Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000259" target="_blank">
                            MAXO:0000259
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Essential treatment to replace the missing insulin and regulate blood glucose levels.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (10 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21584767" target="_blank">PMID:21584767</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Insulin therapy is a vital hormone replacement therapy in type 1 diabetes mellitus."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36476434" target="_blank">PMID:36476434</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The current standard method for type 1 diabetes (T1D) management majorly focuses on controlling blood glucose levels with exogeneous insulin administration."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32342453" target="_blank">PMID:32342453</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"T1DM is caused by absolute lack of insulin secretion, so the current treatment for T1DM patients is exogenous insulin replacement therapy."</div>
                
                
            </div>
            
            
            <div class="evidence-more">+ 7 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Blood Glucose Monitoring
                    
                </div>
                
                <div class="item-desc">Regular monitoring to manage glucose levels effectively.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30215903" target="_blank">PMID:30215903</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There is considerable benefit of tight glucose control in patients with type 1 diabetes mellitus. ... Greater frequency of glucose monitoring and continuous glucose monitoring are both associated with lower A1C levels."</div>
                
                
                <div class="evidence-explanation">The abstract emphasizes the importance of glucose monitoring in managing type 1 diabetes, supporting the statement that regular monitoring is crucial for effective glucose level management.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32256447" target="_blank">PMID:32256447</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Regular self-monitoring of blood glucose levels, and ketones when indicated, is an essential component of type 1 diabetes (T1D) management."</div>
                
                
                <div class="evidence-explanation">The abstract reaffirms that regular monitoring of blood glucose is essential for managing type 1 diabetes, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38551884" target="_blank">PMID:38551884</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Blood glucose monitoring has been an integral part of diabetes treatment for many years, whether for type 1 diabetic patients on multiple daily injections of insulin, insulin pumps or artificial pancreas, and now for patients with type 2 diabetes..."</div>
                
                
                <div class="evidence-explanation">The abstract describes blood glucose monitoring as a cornerstone in diabetes treatment, which includes the management of type 1 diabetes, thus supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Lifestyle Modifications
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000088" target="_blank">
                            MAXO:0000088
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Maintaining a balanced diet, regular physical activity, and adherence to treatment plans.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9314011" target="_blank">PMID:9314011</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nutrition therapy and physical activity can assist persons with diabetes to achieve metabolic goals. Several lifestyle strategies can be used."</div>
                
                
                <div class="evidence-explanation">The text supports the assertion that maintaining a balanced diet and regular physical activity can assist in managing diabetes through lifestyle modifications.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16529680" target="_blank">PMID:16529680</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The patient and physician must work together to optimize glucose control involving both insulin administration and caloric intake. Exercise has numerous benefits and the type 1 diabetic should take advantage of these benefits."</div>
                
                
                <div class="evidence-explanation">This supports the statement that lifestyle modifications, including diet and physical activity, are important in managing type 1 diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24485215" target="_blank">PMID:24485215</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Poor lifestyle habits (poor diet quality, sedentary behaviours and smoking) are known to be driving factors for increased CMR factors in the general population."</div>
                
                
                <div class="evidence-explanation">The text underlines the significance of maintaining a good lifestyle, including a balanced diet and physical activity, as part of diabetes management.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Immunotherapy (Teplizumab)
                    
                </div>
                
                <div class="item-desc">T-cell-targeting therapy that delays progression from stage 2 to stage 3 disease by approximately 2-3 years in early-stage patients.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36877454" target="_blank">PMID:36877454</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In November 2022, teplizumab was approved in the USA to delay the onset of Stage 3 T1D in adults and pediatric patients 8 years of age and older with Stage 2 T1D"</div>
                
                
                <div class="evidence-explanation">This article documents the FDA approval of teplizumab as the first immunotherapy for delaying type 1 diabetes progression.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Continuous Glucose Monitoring
                    
                </div>
                
                <div class="item-desc">Real-time glucose monitoring systems for improved glycemic control and reduced hypoglycemic events.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34872983" target="_blank">PMID:34872983</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"After CGM introduction, the odds ratio (OR) of achieving the HbA1c target of &lt;7.0% improved at 12 months (OR 2.5, P &lt; 0.001) and was maintained at 24 months"</div>
                
                
                <div class="evidence-explanation">This population-based study demonstrates that continuous glucose monitoring significantly improves glycemic control with sustained improvements in HbA1c target achievement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Viral Infections</div>
                
                <div class="item-desc">May trigger the autoimmune response in genetically susceptible individuals</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (9 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23393684" target="_blank">PMID:23393684</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"One of the environmental risk factors identified by a series of independent studies is represented by viral infection, with strong evidence showing that viruses can indeed infect pancreatic beta cells with consequent effects ranging from functional damage to cell death."</div>
                
                
                <div class="evidence-explanation">This reference mentions that viral infections are a strong environmental risk factor for Type I Diabetes, affecting pancreatic beta cells which can lead to autoimmunity.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22891485" target="_blank">PMID:22891485</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Environmental factors must be involved such as viral infections, toxins from food, cow milk during childhood (instead of breast feeding) or vitamin D deficiency."</div>
                
                
                <div class="evidence-explanation">This reference suggests that viral infections are among several environmental factors associated with Type I Diabetes, but does not pinpoint them as the singularly most critical factor.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34942009" target="_blank">PMID:34942009</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Enteroviruses, especially CoxB and Echo, are most represented."</div>
                
                
                <div class="evidence-explanation">This reference supports the role of viral infections in Type I Diabetes, mentioning enteroviruses among others.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 6 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Early Dietary Factors</div>
                
                <div class="item-desc">Possible risk factors include early exposure to cow&#39;s milk and gluten</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8741809" target="_blank">PMID:8741809</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There is a relationship between early cow&#39;s milk exposure and the development of Type 1 diabetes in humans, and between early cow&#39;s milk exposure and the development of autoimmune diabetes in rodent models of Type 1 diabetes."</div>
                
                
                <div class="evidence-explanation">The reference supports early dietary factors such as cow&#39;s milk exposure but indicates that the data are insufficient to conclude a causal relationship.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26605913" target="_blank">PMID:26605913</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Recently, the results of two large randomized trials have shown that breastfeeding in general, breastfeeding during gluten introduction, and early or delayed gluten introduction do not influence the total risk of CD in genetically predisposed individuals."</div>
                
                
                <div class="evidence-explanation">The reference suggests that early or delayed introduction of gluten does not influence the risk of celiac disease, type 1 diabetes mellitus, and wheat allergy, providing no supporting evidence for early dietary factors as risk factors for Type 1 diabetes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20640941" target="_blank">PMID:20640941</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Given that type 1 diabetes, and its preclinical autoimmunity, appear early in life, infant and childhood diet have been implicated as potential initiating exposures in the etiology of the disease."</div>
                
                
                <div class="evidence-explanation">The reference implicates early dietary factors in the risk of Type 1 diabetes but also highlights inconsistencies and the need for further research.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Blood Glucose
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6378696" target="_blank">PMID:6378696</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Elevations of fasting blood glucose and peak glucose during oral glucose tolerance tests were not observed until the year before onset of clinically overt diabetes."</div>
                
                
                <div class="evidence-explanation">This reference suggests that elevated blood glucose is present, but only becomes noticeable in the year before the onset of type 1 diabetes, not necessarily &#39;VERY_FREQUENT&#39; earlier on.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33595181" target="_blank">PMID:33595181</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Glycogenic hepatopathy (GH) in type 1 diabetes-mellitus (T1DM) is characterized by hepatomegaly and perturbations of liver chemistries (LC) that have not been well studied."</div>
                
                
                <div class="evidence-explanation">The focus of this study is on liver chemistries in glycogenic hepatopathy associated with type 1 diabetes, not specifically on the frequency of elevated blood glucose.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18502304" target="_blank">PMID:18502304</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease... microvascular complications...hyperglycaemia is indeed a mediator of cardiovascular risk in type 1 diabetes."</div>
                
                
                <div class="evidence-explanation">This reference supports that elevated blood glucose (hyperglycaemia) is a common and significant factor in type 1 diabetes, indicating that it is &#39;VERY_FREQUENT&#39;.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Hemoglobin A1c (HbA1c)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22847316" target="_blank">PMID:22847316</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The measure of glycated hemoglobin (HbA1c) concentration is the gold standard of glycemic control index in diabetes management and is well known as a marker for diabetes complications."</div>
                
                
                <div class="evidence-explanation">Hemoglobin A1c is frequently measured in the management of diabetes, including Type I diabetes, and elevated levels are indicative of poor glycemic control.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26397266" target="_blank">PMID:26397266</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hemoglobin A1c is the accepted measure of long-term plasma glucose control in diabetics (levels &gt;/=7 percent reflect poor blood glucose control)."</div>
                
                
                <div class="evidence-explanation">Elevated HbA1c levels are a common indicator used in the management of diabetes, supporting the claim of frequent elevated HbA1c in Type I diabetes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Type I Diabetes
category: Metabolic
parents:
- Autoimmune Disease
- Diabetes Mellitus
prevalence:
- population: Global
  percentage: 0.1-0.2
  evidence:
  - reference: PMID:34599655
    supports: REFUTE
    snippet: Global numbers of incident and prevalent cases of type 1 diabetes were
      estimated to be 234,710 and 9,004,610, respectively, in 2017...Globally, type
      1 diabetes represents about 2% of the estimated total cases of diabetes.
    explanation: The prevalence of type 1 diabetes globally is estimated to be around
      2%, not 0.1-0.2%.
  - reference: PMID:16085737
    supports: NO_EVIDENCE
    snippet: The global prevalence of diabetes for all age groups is estimated to
      be 2.8%. Type 2 diabetes accounts for at least 90% of diabetes worldwide.
    explanation: This study provides global prevalence data for diabetes in general
      and specifically mentions Type 2 diabetes but does not give a percentage for
      the prevalence of Type 1 diabetes.
  - reference: PMID:27959859
    supports: REFUTE
    snippet: The incidence of childhood-onset type 1 diabetes has been increasing
      at a rate of 3%-5% per year globally...no means for a practical &#39;cure&#39; exist.
    explanation: The increasing incidence suggests a prevalence higher than 0.1-0.2%.
progression:
- phase: Onset
  age_range: Childhood-Adolescence
  evidence:
  - reference: PMID:33825933
    supports: SUPPORT
    snippet: The incidence of type 1 diabetes (T1D) has been rising steadily over
      the last 30 years, especially among children and adolescents, with the result
      that the number of cases in this age group doubles every 20 years.
    explanation: This study discusses the rising incidence of type 1 diabetes in children
      and adolescents, which aligns with the progression of T1D during childhood and
      adolescence.
  - reference: PMID:30628751
    supports: PARTIAL
    snippet: Twenty-one percent of subjects developed T1D by age 6. Logistic regression
      modeling identified 5 significant predictors.
    explanation: This study focuses on predictors of T1D progression in children with
      high-risk HLA genes followed in The TEDDY study, providing partial support since
      it includes childhood but doesn&#39;t explicitly cover adolescence.
  - reference: PMID:20723813
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference only provides a foreword and does not include specific
      information about the progression phase or onset of Type 1 Diabetes.
  - reference: PMID:26404926
    supports: SUPPORT
    snippet: Stage 3 as onset of symptomatic disease ... Adoption of this staging
      classification provides a standardized taxonomy for type 1 diabetes.
    explanation: This reference discusses the presymptomatic stages of T1D leading
      to symptomatic onset, supporting the progression during childhood and adolescence.
  - reference: PMID:31280235
    supports: PARTIAL
    snippet: We aimed to evaluate children with type 1 diabetes (T1D) with early age
      at onset (EAO) for clinical, immune and metabolic features in order to identify
      age-related disease phenotypes.
    explanation: This study focuses on early age at onset and disease phenotypes in
      children, but doesn&#39;t explicitly cover the entire range including adolescence.
  - reference: PMID:33274481
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference title suggests outcomes over a 20-year period but doesn&#39;t
      provide specific data on the progression phase or onset of Type 1 Diabetes during
      childhood and adolescence in the provided abstract.
  - reference: PMID:26816135
    supports: SUPPORT
    snippet: Type 1 diabetes accounted for 368/421 (87.4 %) patients with age of onset
      &lt;18 y and 99/156 (63.5 %) of patients with onset between 19 and 25 y of age.
    explanation: This study identifies the proportion of various types of diabetes
      in youth, including the onset of T1D in children and adolescents.
pathophysiology:
- name: Genetic Susceptibility
  description: Certain HLA gene variants (HLA-DQ2, HLA-DQ8) and other susceptibility
    genes (INS) increase the risk of developing Type I Diabetes.
  genes:
  - preferred_term: HLA-DQ2
  - preferred_term: HLA-DQ8
  - preferred_term: INS
    term:
      id: hgnc:6081
      label: INS
  downstream:
  - target: Autoimmune Destruction of Beta Cells
  evidence:
  - reference: PMID:11554771
    supports: SUPPORT
    snippet: The HLA-DQ genes are the primary susceptibility genes within this region,
      although other genes may also contribute. The IDDM2 locus maps to a variable
      number of tandem repeats in the insulin gene region on chromosome 11.
    explanation: The provided literature confirms that HLA-DQ and INS genes contribute
      to the genetic susceptibility to Type 1 Diabetes.
  - reference: PMID:31331105
    supports: SUPPORT
    snippet: HLA DQA1*05 and DQB1*02 alleles encoding the DQ2.5 molecule and HLA DQA1*03
      and DQB1*03 alleles encoding DQ8 molecules are strongly associated with celiac
      disease (CD) and type 1 diabetes (T1D), two common autoimmune diseases (AD)
    explanation: The presence of HLA-DQ2 and HLA-DQ8 variants contributing to the
      genetic susceptibility of Type I Diabetes is supported.
  - reference: PMID:3309680
    supports: SUPPORT
    snippet: Over half of the inherited predisposition to insulin-dependent diabetes
      mellitus maps to the region of chromosome 6 that contains the highly polymorphic
      HLA class II genes which determine immune responsiveness.
    explanation: HLA class II genes, including HLA-DQ, play significant roles in the
      predisposition to Type I Diabetes.
  - reference: PMID:15342014
    supports: SUPPORT
    snippet: Accumulating evidence suggests that MHC susceptibility for T1D is recessive,
      with susceptibility alleles more common than protective alleles.
    explanation: The literature indicates that HLA alleles, specifically susceptibility
      alleles, are significant in the context of Type I Diabetes.
  - reference: PMID:17130534
    supports: SUPPORT
    snippet: DQ8 and DQ2 are associated with susceptibility to and DQ6 with protection
      from type 1 diabetes mellitus (T1DM).
    explanation: The association of HLA-DQ2 and HLA-DQ8 with susceptibility to Type
      I Diabetes is supported by this reference.
  - reference: PMID:17496359
    supports: SUPPORT
    snippet: Susceptibility to T1D is strongly linked to a major genetic locus that
      is the major histocompatibility complex (MHC) and several other minor loci including
      insulin, CTLA4 that contribute to diabetes risk in an epistatic way.
    explanation: INS gene contribution to the susceptibility of Type I Diabetes is
      supported along with HLA genes.
- name: Environmental Triggers
  description: Viral infections or early dietary factors (cow&#39;s milk, gluten) may
    trigger the autoimmune response in genetically susceptible individuals.
  triggers:
  - preferred_term: Viral Infections
  - preferred_term: Early Dietary Factors
  downstream:
  - target: Autoimmune Destruction of Beta Cells
  evidence:
  - reference: PMID:10522815
    supports: SUPPORT
    snippet: Various exogenous triggers, such as certain dietary factors and viruses,
      are thought to induce the autoimmune process leading in some individuals to
      extensive beta-cell destruction and ultimately to the clinical manifestation
      of type 1 diabetes.
    explanation: This reference supports the statement by mentioning that dietary
      factors and viruses can trigger the autoimmune process in genetically susceptible
      individuals.
  - reference: PMID:21162649
    supports: SUPPORT
    snippet: The ability to induce strong cellular immune responses and to cause inflammation
      in the target organ makes viral infections prime candidates for the initiation
      of islet autoreactivity.
    explanation: The reference supports the role of viral infections in triggering
      autoimmune responses leading to type 1 diabetes.
  - reference: PMID:18357774
    supports: SUPPORT
    snippet: The most often cited environmental agents implicated as initiators of
      T1D are the human enteroviruses, in particular the group B coxsackieviruses
      (CVB).
    explanation: This reference supports the statement by identifying enteroviruses
      as environmental triggers for type 1 diabetes.
  - reference: PMID:9645989
    supports: SUPPORT
    snippet: dmsee@uci.edu Serologic case-control studies have suggested an association
      between coxsasckie group B viruses and insulin-dependent diabetes mellitus (IDDM)
    explanation: This reference supports the role of viral infections in the onset
      of type 1 diabetes.
  - reference: PMID:31593953
    supports: SUPPORT
    snippet: Viral infections and early exposure to gluten or cow&#39;&#39;s milk in the infant
      diet have been implicated in disease pathogenesis.
    explanation: The reference supports the statement by linking viral infections
      and early dietary factors to the pathogenesis of type 1 diabetes.
- name: Interferon-Driven Beta Cell Response
  description: Type I and type II interferons upregulate antigen presentation and chemokine
    production in beta cells while downregulating oxidative phosphorylation, increasing
    immunogenicity and metabolic stress.
  cell_types:
  - preferred_term: type B pancreatic cell
    term:
      id: CL:0000169
      label: type B pancreatic cell
  biological_processes:
  - preferred_term: type I interferon signaling pathway
    term:
      id: GO:0060337
      label: type I interferon signaling pathway
  - preferred_term: antigen processing and presentation of peptide antigen via MHC class I
    term:
      id: GO:0002474
      label: antigen processing and presentation of peptide antigen via MHC class I
  - preferred_term: chemokine production
    term:
      id: GO:0032602
      label: chemokine production
  - preferred_term: oxidative phosphorylation
    term:
      id: GO:0006119
      label: oxidative phosphorylation
    modifier: DECREASED
  chemical_entities:
  - preferred_term: interferon-alpha
    description: Type I interferon that drives antiviral and antigen-presentation programs
  - preferred_term: interferon-gamma
    description: Type II interferon that induces HLA class I upregulation and chemokine production
  - preferred_term: C-X-C motif chemokine 10
    description: Chemokine (CXCL10) that recruits autoreactive T cells to islets
  downstream:
  - target: Autoimmune Destruction of Beta Cells
  evidence:
  - reference: PMID:38409439
    supports: SUPPORT
    snippet: IFN-Œ± and IFN-Œ≥ had a greater impact on the beta cell transcriptome when
      compared with IL-1Œ≤ and TNF-Œ±. The IFN-induced gene signatures have a strong
      correlation with those observed in beta cells from individuals with type 1 diabetes.
    explanation: This study identifies interferons as key drivers of beta cell inflammatory
      responses, upregulating antigen presentation and chemokine production.
- name: Autoimmune Destruction of Beta Cells
  description: The immune system mistakenly targets and destroys insulin-producing
    beta cells in the pancreas through T cell-mediated cytotoxicity and autoantibody production.
  cell_types:
  - preferred_term: type B pancreatic cell
    term:
      id: CL:0000169
      label: type B pancreatic cell
  - preferred_term: CD8-positive, alpha-beta cytotoxic T cell
    term:
      id: CL:0000794
      label: CD8-positive, alpha-beta cytotoxic T cell
  - preferred_term: CD4-positive, alpha-beta T cell
    term:
      id: CL:0000624
      label: CD4-positive, alpha-beta T cell
  - preferred_term: regulatory T cell
    term:
      id: CL:0000815
      label: regulatory T cell
  - preferred_term: B cell
    term:
      id: CL:0000236
      label: B cell
  - preferred_term: dendritic cell
    term:
      id: CL:0000451
      label: dendritic cell
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: T cell mediated cytotoxicity
    term:
      id: GO:0001913
      label: T cell mediated cytotoxicity
  - preferred_term: autoantibody production
    modifier: ABNORMAL
  - preferred_term: cytokine-mediated signaling pathway
    term:
      id: GO:0019221
      label: cytokine-mediated signaling pathway
  locations:
  - preferred_term: pancreatic islet
    term:
      id: UBERON:0000006
      label: islet of Langerhans
  downstream:
  - target: Insulin Deficiency
    description: Autoimmune destruction of pancreatic beta cells leads to absolute
      or near-absolute insulin deficiency.
    evidence:
    - reference: PMID:40734585
      supports: SUPPORT
      snippet: Type 1 diabetes is characterised by the autoimmune destruction of pancreatic
        Œ≤‚Äêcells, leading to an absolute or near‚Äêabsolute insulin deficiency.
      explanation: This 2025 review clearly establishes the causal chain from autoimmune
        destruction of beta cells to absolute insulin deficiency that characterizes
        Type 1 Diabetes.
  evidence:
  - reference: PMID:12185667
    supports: PARTIAL
    snippet: Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease that
      results in the destruction of the insulin-producing beta cells in the pancreatic
      islets of Langerhans.
    explanation: While T-cell mediated cytotoxicity is mentioned, there is no reference
      to autoantibody production.
  - reference: PMID:23774118
    supports: PARTIAL
    snippet: Phenotypes of infiltrating cells around and/or into islets were mainly
      dendritic cells, macrophages and CD8+ T cells.
    explanation: Supports T cell-mediated cytotoxicity but does not discuss autoantibody
      production.
  - reference: PMID:27659143
    supports: PARTIAL
    snippet: The autoimmune destruction of the pancreatic islet beta cells is due
      to a targeted lymphocyte attack.
    explanation: Supports T cell-mediated cytotoxicity but does not mention autoantibody
      production.
  - reference: PMID:27017348
    supports: PARTIAL
    snippet: Type 1 diabetes (T1D) is an autoimmune disorder characterized by the
      destruction of insulin-producing pancreatic beta cells.
    explanation: Describes immune-mediated destruction of beta cells but does not
      specifically mention autoantibody production.
  - reference: PMID:16280652
    supports: PARTIAL
    snippet: Type 1 diabetes results from the destruction of insulin-producing pancreatic
      beta cells by a beta cell-specific autoimmune process.
    explanation: Supports T cell-mediated cytotoxicity but does not address autoantibody
      production.
  - reference: PMID:34691077
    supports: PARTIAL
    snippet: Type 1 diabetes (T1D) is an autoimmune disease characterized by autoreactive
      T cell-mediated destruction of insulin-producing pancreatic beta-cells.
    explanation: Supports T cell-mediated cytotoxicity but lacks information on autoantibody
      production.
  - reference: PMID:33479911
    supports: PARTIAL
    snippet: Type 1 diabetes is an organ-specific autoimmune disease characterized
      by immune-mediated beta cell destruction in pancreatic islets.
    explanation: Describes immune-mediated destruction but not autoantibody production.
  - reference: PMID:28625830
    supports: PARTIAL
    snippet: Type 1 diabetes is an autoimmune disease marked by the destruction of
      insulin-producing beta cells in the pancreatic islets.
    explanation: Indicates immune destruction of beta cells but does not mention autoantibody
      production.
- name: Insulin Deficiency
  description: Loss of beta cells leads to a deficiency of insulin, a hormone required
    for glucose uptake.
  downstream:
  - target: Hyperglycemia
  - target: Impaired Glucose Utilization
  - target: Increased Lipolysis
  evidence:
  - reference: PMID:35254878
    supports: SUPPORT
    snippet: Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic
      beta cells stop producing insulin, typically due to autoimmune destruction.
    explanation: This confirms that the loss of beta cells leads to a deficiency of
      insulin in Type 1 diabetes, as stated in the provided statement.
  - reference: PMID:21281836
    supports: SUPPORT
    snippet: Insulin resistance and defective glucose sensing at the beta-cell are
      the central pathophysiologic determinants that together cause hyperglycemia.
    explanation: Although it primarily discusses prediabetes and Type 2 diabetes,
      the excerpt supports the idea that beta-cell issues lead to hyperglycemia.
  - reference: PMID:2006409
    supports: SUPPORT
    snippet: Glucose uptake into pancreatic beta cells by means of the glucose transporter
      GLUT-2, which has a high Michaelis constant, is essential for the normal insulin
      secretory response to hyperglycemia.
    explanation: This indicates the importance of beta cells in glucose regulation
      and the resulting hyperglycemia when their function is impaired.
  - reference: PMID:11822099
    supports: SUPPORT
    snippet: Peripheral insulin-resistance and impairment of the hepatocellular function
      are two major possible causes of diabetes mellitus in liver cirrhosis.
    explanation: This reference is more about liver cirrhosis but supports the general
      mechanism where insulin deficiency, due to impaired beta-cell function, leads
      to diabetes.
  - reference: PMID:11508279
    supports: SUPPORT
    snippet: Loss of blood glucose control might result from failure of the beta cells
      to secrete insulin, resistance of the tissues to its action, or a combination
      of both.
    explanation: This also supports the idea that loss of beta cells leads to insulin
      deficiency and subsequent glucose control issues, relevant to both Type 1 and
      Type 2 diabetes.
- name: Hyperglycemia
  description: Lack of insulin results in high blood glucose levels, as glucose cannot
    be efficiently taken up by cells.
  assays:
  - preferred_term: Elevated Blood Glucose
  - preferred_term: Elevated Hemoglobin A1c (HbA1c)
  downstream:
  - target: Glucosuria
  - target: Polyuria
  - target: Polydipsia
  - target: Diabetic Ketoacidosis (DKA)
  evidence:
  - reference: PMID:33970586
    supports: SUPPORT
    snippet: Type 1 diabetes is defined as a state of hyperglycemia due to insulin
      deficiency caused by autoimmune pancreatic beta-cell destruction.
    explanation: The abstract from PMID:33970586 confirms that type 1 diabetes is
      characterized by hyperglycemia due to insulin deficiency, which supports the
      statement regarding elevated blood glucose and related downstream effects.
  - reference: PMID:37921158
    supports: PARTIAL
    snippet: HbA1c offers a trustworthy indicator of chronic hyperglycemia and strongly
      correlates with the likelihood of long-term consequences from diabetes.
    explanation: Although this reference supports the relationship between elevated
      HbA1c and hyperglycemia, it does not specifically address all the downstream
      effects such as Glucosuria, Polyuria, Polydipsia, and Diabetic Ketoacidosis
      (DKA).
  - reference: PMID:21281836
    supports: NO_EVIDENCE
    snippet: The phenotype of prediabetes includes dyslipidemia and higher arterial
      blood pressure.
    explanation: This study does not specifically address the pathophysiology of type
      1 diabetes or the particular assays and downstream effects mentioned in the
      statement.
  - reference: PMID:11921414
    supports: NO_EVIDENCE
    snippet: Lack of insulin production or abnormalities affecting insulin secretion
      are key to the development of almost all forms of diabetes.
    explanation: While it mentions insulin deficiency, this reference does not go
      into detail about the specific assays and downstream effects listed in the statement.
  - reference: PMID:15137354
    supports: NO_EVIDENCE
    snippet: The article points out the signs and symptoms to be aware of when the
      person is in the acute state of diabetic ketoacidosis.
    explanation: This article touches on diabetic ketoacidosis but does not fully
      cover all the listed downstream effects and assays associated with type 1 diabetes
      pathophysiology.
- name: Impaired Glucose Utilization
  description: Without insulin, cells are unable to utilize glucose for energy production,
    leading to cellular energy deficiency.
  downstream:
  - target: Weight Loss
  - target: Fatigue
  evidence:
  - reference: PMID:12477252
    supports: SUPPORT
    snippet: Type 1 or insulin-dependent diabetes mellitus is caused by autoimmune
      attack and selective destruction of the pancreatic beta cells.
    explanation: The lack of insulin in type 1 diabetes mellitus leads to impaired
      glucose utilization as described in the statement.
  - reference: PMID:15137354
    supports: SUPPORT
    snippet: The following article reviews the basic pathophysiology of both type
      1 diabetes mellitus and type 2 diabetes mellitus as we understand it today.
    explanation: This article explains that in diabetes, particularly type 1, the
      lack of insulin results in impaired glucose utilization, leading to characteristic
      symptoms like weight loss and fatigue.
- name: ER Stress and Unfolded Protein Response
  description: Inflammatory cytokines induce endoplasmic reticulum stress in beta cells,
    activating the unfolded protein response and contributing to beta cell dysfunction and apoptosis.
  cell_types:
  - preferred_term: type B pancreatic cell
    term:
      id: CL:0000169
      label: type B pancreatic cell
  biological_processes:
  - preferred_term: endoplasmic reticulum unfolded protein response
    term:
      id: GO:0030968
      label: endoplasmic reticulum unfolded protein response
  - preferred_term: apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
  chemical_entities:
  - preferred_term: interleukin-1beta
    description: Proinflammatory cytokine that contributes to beta-cell stress and ER dysfunction
  downstream:
  - target: Autoimmune Destruction of Beta Cells
  evidence:
  - reference: PMID:38409439
    supports: SUPPORT
    snippet: IFN-Œ± and IFN-Œ≥ had a greater impact on the beta cell transcriptome when
      compared with IL-1Œ≤ and TNF-Œ±. The IFN-induced gene signatures have a strong
      correlation with those observed in beta cells from individuals with type 1 diabetes.
    explanation: This study shows interferons drive beta cell stress responses including
      ER stress pathways that contribute to beta cell dysfunction and death.
- name: Increased Lipolysis
  description: Insulin deficiency also leads to increased breakdown of fat (lipolysis)
    for energy, resulting in the production of ketones.
  downstream:
  - target: Diabetic Ketoacidosis (DKA)
  evidence:
  - reference: PMID:6409465
    supports: SUPPORT
    snippet: Insulin deficiency results in increased rates of lipolysis and provides
      increased substrate (free fatty acids) for ketogenesis.
    explanation: The article explains that insulin deficiency leads to increased lipolysis,
      which eventually results in the production of ketone bodies. This supports the
      statement&#39;s claim about the pathophysiology involving lipolysis and ketone production
      in Type I Diabetes.
  - reference: PMID:15137354
    supports: SUPPORT
    snippet: The article points out the signs and symptoms to be aware of when the
      person is in the acute state of diabetic ketoacidosis.
    explanation: The article suggests that DKA is a critical concern in Type I Diabetes
      due to insufficient insulin, which is aligned with the statement indicating
      the downstream effect of heightened lipolysis and ketone production.
  - reference: PMID:34922394
    supports: PARTIAL
    snippet: the involvement of B:9-23rPep-specific IFN-gamma-related immunoreactivity
      in the pathophysiology of some unprovoked A-beta+ KPD.
    explanation: Although the study highlights immune responses related to ketosis-prone
      Type 2 Diabetes, it indirectly supports the notion that immune-mediated processes
      can contribute to ketosis and DKA.
- name: Chronic Complications
  description: Persistent hyperglycemia over time can lead to damage in various tissues
    and organs.
  downstream:
  - target: Retinopathy
  - target: Neuropathy
  - target: Nephropathy
  - target: Cardiovascular Disease
  evidence:
  - reference: PMID:31346658
    supports: SUPPORT
    snippet: Hyperglycaemia, dyslipidaemia and hypertension combine with the duration
      and type of diabetes to define the distinct pathophysiology underlying diabetic
      kidney disease, diabetic retinopathy and diabetic neuropathy.
    explanation: The literature indicates that hyperglycemia is a significant factor
      in the pathophysiology of diabetic complications including kidney disease (nephropathy),
      retinopathy, and neuropathy, thereby supporting the claim.
  - reference: PMID:34407376
    supports: SUPPORT
    snippet: Hyperglycemia is the common denominator for most of the chronic diabetic
      vascular complications, which represent the main cause of life reduction in
      T1D patients.
    explanation: This reference indicates that hyperglycemia underlies various chronic
      vascular complications in type 1 diabetes, thus supporting the statement.
  - reference: PMID:3528691
    supports: SUPPORT
    snippet: The remaining 15 to 20% of patients have insulin-dependent diabetes mellitus,
      a disorder caused by the destruction of insulin-producing endocrine cells within
      the pancreas and currently considered to be the result of an autoimmune process.
      During the course of both types of diabetes mellitus, the so-called long-term
      complications of diabetes invariably occur to some extent in all patients. These
      complications include retinopathy, nephropathy, neuropathy, and premature atherosclerosis.
    explanation: The study confirms that type 1 diabetes, which involves insulin-dependent
      diabetes mellitus, results in long-term complications such as retinopathy, nephropathy,
      neuropathy, and cardiovascular disease.
  - reference: PMID:35456511
    supports: SUPPORT
    snippet: The prevention of hyperglycemia is very important to avoid or at least
      postpone the development of micro- and macrovascular complications, also known
      as late complications. These include diabetic retinopathy, chronic renal failure,
      diabetic neuropathy, and cardiovascular diseases.
    explanation: The literature points out that hyperglycemia leads to microvascular
      (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular diseases)
      complications, supporting the statement.
- name: Diabetic Ketoacidosis (DKA)
  description: Life-threatening metabolic emergency from insulin deficiency
phenotypes:
- category: Endocrine
  name: Hyperglycemia
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Diabetic Ketoacidosis
  evidence:
  - reference: PMID:38272591
    supports: SUPPORT
    snippet: Type 1 diabetes is associated with both acute and chronic complications.
      Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic
      complications can be microvascular or macrovascular. Microvascular complications
      include retinopathy, nephropathy, and neuropathy.
    explanation: This source supports the statement by associating Type I Diabetes
      with hyperglycemia and chronic complications such as retinopathy and neuropathy,
      as well as acute complications like diabetic ketoacidosis.
  - reference: PMID:28544185
    supports: SUPPORT
    snippet: Participation in prospective follow-up studies reduces the frequency
      of DKA in children at diagnosis of T1D, but genetic screening alone does not
      decrease DKA risk.
    explanation: This source supports the statement by confirming that Diabetic Ketoacidosis
      (DKA) is a frequent acute complication in Type 1 Diabetes at the time of diagnosis.
  - reference: PMID:34362315
    supports: SUPPORT
    snippet: Although SH was usually benign and long-term treatment was superfluous,
      it might be the first sign of insulinopenic status such as type 1 DM (T1DM)
    explanation: This source supports the statement by describing stress hyperglycemia
      as a potential initial presentation of Type 1 Diabetes, thereby confirming hyperglycemia
      as a very frequent occurrence.
  phenotype_term:
    preferred_term: Hyperglycemia
    term:
      id: HP:0003074
      label: Hyperglycemia
- category: Systemic
  name: Weight Loss
  frequency: FREQUENT
  notes: Due to inability to utilize glucose for energy
  evidence:
  - reference: PMID:23075321
    supports: PARTIAL
    snippet: Immune-mediated (auto-immune) Type 1 diabetes mellitus is not a homogenous
      entity, but nonetheless has distinctive characteristics. In children, it may
      present with classical insulin deficiency and ketoacidosis at disease onset,
      whereas autoimmune diabetes in adults may not always be insulin dependent.
    explanation: The source does indicate that Type 1 diabetes has varied presentations,
      including insulin deficiency and potentially weight loss due to failure to utilize
      glucose. However, the excerpt does not specifically mention weight loss as a
      frequent phenotype.
  - reference: PMID:12949265
    supports: NO_EVIDENCE
    explanation: The provided literature does not directly discuss weight loss as
      a frequent systemic phenotype of Type 1 diabetes.
  - reference: PMID:11508279
    supports: NO_EVIDENCE
    explanation: This reference discusses the Accelerator Hypothesis and weight gain
      in diabetes but does not address weight loss in Type 1 diabetes.
  - reference: PMID:37065759
    supports: PARTIAL
    snippet: The risk factors of weight gain included using exogenous insulin, intensifying
      insulin therapy, fear of hypoglycemia and related decrease in physical activity,
      and psychological factors, such as emotional eating and binge eating
    explanation: This reference addresses weight gain in relation to Type 1 Diabetes
      but does not state that weight loss is a frequent phenotype.
  - reference: PMID:19267337
    supports: NO_EVIDENCE
    explanation: The reference discusses the natural history of endogenous beta-cell
      function in Type 1 diabetes but does not mention weight loss being a frequent
      phenotype.
  phenotype_term:
    preferred_term: Weight loss
    term:
      id: HP:0001824
      label: Weight loss
- category: Systemic
  frequency: FREQUENT
  name: Polyuria
  notes: Caused by osmotic diuresis from hyperglycemia
  evidence:
  - reference: PMID:35254878
    supports: SUPPORT
    snippet: Symptoms include polyuria, polydipsia, and weight loss.
    explanation: This reference confirms that polyuria is a frequent symptom of Type
      I Diabetes.
  - reference: PMID:2923250
    supports: SUPPORT
    snippet: Poorly controlled insulin-dependent diabetes mellitus is associated with
      considerable elevations of plasma vasopressin concentrations, although well-controlled
      diabetics have normal osmoregulated thirst and vasopressin release.
    explanation: This reference discusses the association of poorly controlled insulin-dependent
      diabetes mellitus (Type I Diabetes) with symptoms such as polyuria.
  phenotype_term:
    preferred_term: Polyuria
    term:
      id: HP:0000103
      label: Polyuria
- category: Systemic
  frequency: FREQUENT
  name: Polydipsia
  notes: Excessive thirst due to dehydration from polyuria
  evidence:
  - reference: PMID:35254878
    supports: SUPPORT
    snippet: Symptoms include polyuria, polydipsia, and weight loss.
    explanation: The reference clearly states that polydipsia is a symptom of Type
      1 Diabetes Mellitus, supporting the statement that it is a frequent systemic
      occurrence.
  phenotype_term:
    preferred_term: Polydipsia
    term:
      id: HP:0001959
      label: Polydipsia
- category: Endocrine
  frequency: OCCASIONAL
  name: Diabetic Ketoacidosis
  notes: Life-threatening complication of insulin deficiency
  sequelae:
  - target: Abdominal Pain
  - target: Vomiting
  - target: Rapid Breathing
  - target: Confusion
  evidence:
  - reference: PMID:12474677
    supports: PARTIAL
    snippet: Diabetic ketoacidosis is an emergency medical condition that can be life-threatening
      if not treated properly. Diabetic ketoacidosis occurs most often in patients
      with type 1 diabetes (formerly called insulin-dependent diabetes mellitus);
      however, its occurrence in patients with type 2 diabetes (formerly called noninsulin-dependent
      diabetes mellitus) is not as rare as was once thought.
    explanation: The literature supports that diabetic ketoacidosis is a life-threatening
      complication of type 1 diabetes and mentions symptoms such as abdominal pain
      and vomiting. However, it does not specify the frequency as &#39;occasional&#39;.
  - reference: PMID:17627511
    supports: PARTIAL
    snippet: A small group of patients affected by type 1 diabetes mellitus is characterized
      by a severe instability of glycemic values with frequent and unpredictable hypoglycemic
      and/or ketoacidosis episodes which cannot be explained by errors of patients
      or diabetologists.
    explanation: This reference supports the occurrence of diabetic ketoacidosis in
      type 1 diabetes and mentions its life-threatening nature but does not confirm
      the frequency as &#39;occasional&#39;.
  - reference: PMID:15137354
    supports: PARTIAL
    snippet: The article points out the signs and symptoms to be aware of when the
      person is in the acute state of diabetic ketoacidosis, hyperglycemic hyperosmolar
      nonketotic coma (or state), and severe hypoglycemia.
    explanation: The reference confirms that diabetic ketoacidosis is a life-threatening
      complication of type 1 diabetes and includes symptoms like confusion and rapid
      breathing but does not specify the frequency as &#39;occasional&#39;.
  - reference: PMID:35466445
    supports: PARTIAL
    snippet: Diabetic ketoacidosis as a unique initial presentation of cystic fibrosis.
    explanation: This reference indicates that diabetic ketoacidosis can be a presentation
      in type 1 diabetes but does not address the frequency or the specific symptoms
      listed.
  phenotype_term:
    preferred_term: Diabetic Ketoacidosis
    term:
      id: HP:0001953
      label: Diabetic ketoacidosis
- category: Ophthalmologic
  frequency: OCCASIONAL
  name: Diabetic Retinopathy
  notes: Leading cause of blindness, due to chronic hyperglycemia
  evidence:
  - reference: PMID:24864506
    supports: NO_EVIDENCE
    snippet: Diabetes mellitus (DM), due to its epidemic prevalence and high occurrence
      of associated disability, is now one of the priority medical and social problems.
      Incapacitating manifestations of diabetes include visual impairment. Thus, diabetic
      retinopathy (DR), a late nonspecific vascular complication of DM, is the leading
      cause of blindness in the working-age population.
    explanation: The literature mentions diabetic retinopathy as a leading cause of
      blindness in the working-age population but does not provide specific information
      on its frequency in Type I Diabetes.
  - reference: PMID:37469057
    supports: NO_EVIDENCE
    snippet: The commonest morbidity was cataract12,607(28.8%), followed by refractive
      errors 8,508(19.5%), vision-threatening diabetic retinopathy 2,553(5.83%) and
      suspected glaucoma 1,211(2.76%).
    explanation: The study provides data on the prevalence of diabetic retinopathy
      in a diabetic population but does not specify it as occasional in Type I Diabetes.
  - reference: PMID:38272591
    supports: NO_EVIDENCE
    snippet: Type 1 diabetes is associated with both acute and chronic complications.
      Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic
      complications can be microvascular or macrovascular. Microvascular complications
      include retinopathy, nephropathy, and neuropathy.
    explanation: The article mentions retinopathy as a complication of Type 1 diabetes
      but does not specify its frequency as occasional.
  - reference: PMID:29682912
    supports: NO_EVIDENCE
    snippet: Diabetic retinopathy, a complication of both type 1 and type 2 diabetes,
      is a complex disease and is one of the leading causes of blindness in adults
      worldwide.
    explanation: The literature mentions diabetic retinopathy as a complication of
      Type 1 and Type 2 diabetes but does not specify its frequency as occasional.
- category: Neurologic
  frequency: OCCASIONAL
  name: Diabetic Neuropathy
  notes: Nerve damage from chronic hyperglycemia
  evidence:
  - reference: PMID:28159476
    supports: SUPPORT
    snippet: Aggressive glucose control can result in treatment induced neuropathy
      of diabetes (TIND) if glycemic control is achieved too quickly.
    explanation: This reference supports the statement by indicating that aggressive
      glycemic control can lead to diabetic neuropathy, which is a neurologic complication
      of Type I Diabetes.
  - reference: PMID:33071962
    supports: SUPPORT
    snippet: Glycemic variability (GV) may attribute to the pathogenesis of diabetic
      neuropathy.
    explanation: This reference supports the statement that diabetic neuropathy is
      a neurologic complication associated with glycemic variability, which can be
      linked to chronic hyperglycemia.
  - reference: PMID:33715053
    supports: SUPPORT
    snippet: Emerging evidence suggests that hyperglycemia and time in range may be
      more important for brain development than episodes of hypoglycemia.
    explanation: This reference supports the statement by highlighting the role of
      hyperglycemia in neurocognitive complications, which can be related to diabetic
      neuropathy in Type I Diabetes.
  - reference: PMID:23506377
    supports: SUPPORT
    snippet: &#39;&#39;&#39;Insulin neuritis&#39;&#39; or &#39;&#39;treatment induced neuropathy&#39;&#39; is a reversible
      disorder characterised by acute severe distal limb pain, peripheral nerve fibre
      damage and autonomic dysfunction, preceded by a period of rapid glycaemic control.&#39;
    explanation: This reference supports the statement by describing insulin neuritis,
      a form of diabetic neuropathy, which is a neurologic complication associated
      with glycemic control.
- category: Renal
  frequency: OCCASIONAL
  name: Diabetic Nephropathy
  notes: Kidney damage from chronic hyperglycemia
  evidence:
  - reference: PMID:23290727
    supports: NO_EVIDENCE
    snippet: Renal failure in type 2 diabetes has been termed &#39;a medical catastrophe
      of worldwide dimension&#39;.
    explanation: This study primarily discusses renal failure in type 2 diabetes,
      not type 1 diabetes.
  - reference: PMID:27903991
    supports: PARTIAL
    snippet: Diabetic nephropathy (DN) is a serious complication of diabetes mellitus,
      and its prevalence has been increasing in developed countries.
    explanation: The study mentions diabetic nephropathy as a serious complication
      of diabetes mellitus in general, without specifying the frequency in type 1
      diabetes.
  - reference: PMID:1490695
    supports: PARTIAL
    snippet: The most serious complication of diabetes mellitus is clinical nephropathy.
    explanation: The study highlights nephropathy as a serious complication of diabetes
      mellitus but does not specify its frequency in type 1 diabetes.
  - reference: PMID:30833370
    supports: PARTIAL
    snippet: higher mean glycemic exposure was the strongest determinant of kidney
      disease among the modifiable risk factors.
    explanation: The study identifies glycemic control as a significant factor for
      kidney disease in type 1 diabetes but does not specify the frequency of diabetic
      nephropathy.
- category: Renal
  name: Glucosuria
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Glucosuria
    term:
      id: HP:0003076
      label: Glycosuria
- category: Systemic
  name: Fatigue
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- category: Ocular
  name: Retinopathy
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Retinopathy
    term:
      id: HP:0000488
      label: Retinopathy
- category: Neurologic
  name: Neuropathy
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Neuropathy
    term:
      id: HP:0009830
      label: Peripheral neuropathy
- category: Renal
  name: Nephropathy
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Nephropathy
    term:
      id: HP:0000112
      label: Nephropathy
- category: Cardiovascular
  name: Cardiovascular Disease
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Cardiovascular Disease
    term:
      id: HP:0001626
      label: Abnormality of the cardiovascular system
- category: Gastrointestinal
  name: Abdominal Pain
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abdominal Pain
    term:
      id: HP:0002027
      label: Abdominal pain
- category: Gastrointestinal
  name: Vomiting
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Vomiting
    term:
      id: HP:0002013
      label: Vomiting
- category: Respiratory
  name: Rapid Breathing
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Rapid Breathing
    term:
      id: HP:0002789
      label: Tachypnea
- category: Neurologic
  name: Confusion
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Confusion
    term:
      id: HP:0001289
      label: Confusion
biochemical:
- name: Blood Glucose
  presence: Elevated
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:6378696
    supports: PARTIAL
    snippet: Elevations of fasting blood glucose and peak glucose during oral glucose
      tolerance tests were not observed until the year before onset of clinically
      overt diabetes.
    explanation: This reference suggests that elevated blood glucose is present, but
      only becomes noticeable in the year before the onset of type 1 diabetes, not
      necessarily &#39;VERY_FREQUENT&#39; earlier on.
  - reference: PMID:33595181
    supports: NO_EVIDENCE
    snippet: Glycogenic hepatopathy (GH) in type 1 diabetes-mellitus (T1DM) is characterized
      by hepatomegaly and perturbations of liver chemistries (LC) that have not been
      well studied.
    explanation: The focus of this study is on liver chemistries in glycogenic hepatopathy
      associated with type 1 diabetes, not specifically on the frequency of elevated
      blood glucose.
  - reference: PMID:18502304
    supports: SUPPORT
    snippet: Type 1 diabetes is associated with a substantially increased risk of
      cardiovascular disease... microvascular complications...hyperglycaemia is indeed
      a mediator of cardiovascular risk in type 1 diabetes.
    explanation: This reference supports that elevated blood glucose (hyperglycaemia)
      is a common and significant factor in type 1 diabetes, indicating that it is
      &#39;VERY_FREQUENT&#39;.
- name: Hemoglobin A1c (HbA1c)
  presence: Elevated
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:22847316
    supports: SUPPORT
    snippet: The measure of glycated hemoglobin (HbA1c) concentration is the gold
      standard of glycemic control index in diabetes management and is well known
      as a marker for diabetes complications.
    explanation: Hemoglobin A1c is frequently measured in the management of diabetes,
      including Type I diabetes, and elevated levels are indicative of poor glycemic
      control.
  - reference: PMID:26397266
    supports: SUPPORT
    snippet: Hemoglobin A1c is the accepted measure of long-term plasma glucose control
      in diabetics (levels &gt;/=7 percent reflect poor blood glucose control).
    explanation: Elevated HbA1c levels are a common indicator used in the management
      of diabetes, supporting the claim of frequent elevated HbA1c in Type I diabetes.
genetic:
- name: HLA-DQ2
  association: Susceptibility
  evidence:
  - reference: PMID:22184118
    supports: SUPPORT
    snippet: HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes
      (T1D).
    explanation: This study identifies HLA-DQ2 as a strongly predisposing haplotype
      for type 1 diabetes susceptibility.
- name: HLA-DQ8
  association: Susceptibility
  evidence:
  - reference: PMID:22184118
    supports: SUPPORT
    snippet: HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes
      (T1D).
    explanation: This statement specifically mentions HLA-DQ8 as a strong predisposing
      haplotype for type 1 diabetes, supporting the association with susceptibility.
  - reference: PMID:26492519
    supports: SUPPORT
    snippet: The DR3-DQ2/DR4-DQ8 genotype conferred the highest detected risk for
      T1D.
    explanation: This study identifies the DR4-DQ8 genotype as highly associated with
      a risk for developing type 1 diabetes, thus supporting the genetic susceptibility.
  - reference: PMID:34946827
    supports: SUPPORT
    snippet: The combination of HLA-DQA1*03:01 and DQB1*03:02 alleles (summarized
      as &#39;HLA-DQ8&#39;) is reported to be among the two most prevalent HLA class II haplotypes
      in Caucasian type 1 diabetes patients.
    explanation: This reference confirms that HLA-DQ8 is one of the most prevalent
      haplotypes among type 1 diabetes patients in the studied population, supporting
      its association with susceptibility.
- name: INS
  association: Susceptibility
  notes: Insulin gene; VNTR/INS expression influences central and peripheral tolerance to insulin
  evidence:
  - reference: PMID:15529622
    supports: SUPPORT
    snippet: Our results indicate an exceptionally strong association of the class
      I INS-VNTR alleles with T1DM for the Romanian population.
    explanation: The study presents evidence of a strong association between INS-VNTR
      alleles of the insulin gene and susceptibility to type 1 diabetes in the Romanian
      population.
  - reference: PMID:8934932
    supports: SUPPORT
    snippet: Genetic susceptibility predominantly results from specific alleles in
      the HLA complex and insulin gene region.
    explanation: This paper states that genetic susceptibility to insulin-dependent
      diabetes mellitus predominantly results from specific alleles, including those
      in the insulin gene region.
  - reference: PMID:11845220
    supports: SUPPORT
    snippet: However, only within the past decade has it been possible to systematically
      attempt to identify the genes that increase susceptibility to this disorder
      using linkage and association analysis of genetic markers distributed across
      the genome.
    explanation: This study discusses the identification of susceptibility genes for
      type 1 diabetes, including the insulin gene.
  - reference: PMID:11921414
    supports: SUPPORT
    snippet: Because insulin has such a central role in the pathogenesis of both forms
      of diabetes, the insulin gene (INS) has always been considered a candidate susceptibility
      gene.
    explanation: The paper directly states that the insulin gene is considered a candidate
      susceptibility gene.
  - reference: PMID:11347740
    supports: SUPPORT
    snippet: The disease-associated INS genotype (Hph I) was identified in 87.5% of
      the concordant twins but only in 59.5% (P = 0.005) of the discordant twins.
    explanation: The study demonstrates the presence of a disease-associated INS genotype
      in a high percentage of concordant twins for type 1 diabetes.
  - reference: PMID:33483996
    supports: SUPPORT
    snippet: Over half of the genetic risk has been attributed to the human leukocyte
      antigen (HLA) class II gene region and to the insulin (INS) gene locus.
    explanation: This article attributes a significant portion of the genetic risk
      for type 1 diabetes to the insulin (INS) gene locus.
- name: PTPN22
  association: Susceptibility
  notes: Tyrosine phosphatase that negatively regulates TCR signaling; risk alleles alter T cell activation thresholds
  evidence:
  - reference: PMID:15734872
    supports: SUPPORT
    snippet: The homozygous genotype for the T allele encoding the 620W residue is associated with an increased risk for developing type 1 diabetes
    explanation: This study demonstrates that the PTPN22 R620W polymorphism confers significant genetic susceptibility to type 1 diabetes in Caucasian populations.
- name: IL2RA
  association: Susceptibility
  notes: IL-2 receptor alpha chain; modulates regulatory T cell (Treg) fitness and homeostasis
  evidence:
  - reference: PMID:22461703
    supports: SUPPORT
    snippet: CD4(+)CD25(+) regulatory T cells (Tregs) from individuals with a range of human autoimmune diseases, including type 1 diabetes, are deficient in their ability to control autologous proinflammatory responses
    explanation: This study demonstrates that IL2RA variants associated with type 1 diabetes lead to diminished IL-2 responsiveness and impaired regulatory T cell function.
- name: CTLA4
  association: Susceptibility
  notes: Immune-checkpoint receptor that limits T cell activation and promotes tolerance
  evidence:
  - reference: PMID:9353155
    supports: SUPPORT
    snippet: the presence of a G-containing CTLA-4 genotype confers a moderate but significant RR for IDDM that is independent of age and genetic or immune disease markers
    explanation: This study demonstrates that CTLA4 gene polymorphisms confer susceptibility to type 1 diabetes independent of other genetic and immune markers.
- name: TYK2
  association: Susceptibility
  notes: Janus-family kinase in type I IFN/JAK signaling; variants affect interferon responses and beta-cell sensitivity
  evidence: []
- name: IFIH1
  association: Susceptibility
  notes: Cytosolic viral RNA sensor (MDA5) implicated in antiviral signaling and linkage to autoimmune risk
  evidence: []
- name: BACH2
  association: Susceptibility
  notes: Transcriptional regulator controlling immune-cell differentiation and tolerance maintenance
  evidence: []
environmental:
- name: Viral Infections
  notes: May trigger the autoimmune response in genetically susceptible individuals
  evidence:
  - reference: PMID:23393684
    supports: SUPPORT
    snippet: One of the environmental risk factors identified by a series of independent
      studies is represented by viral infection, with strong evidence showing that
      viruses can indeed infect pancreatic beta cells with consequent effects ranging
      from functional damage to cell death.
    explanation: This reference mentions that viral infections are a strong environmental
      risk factor for Type I Diabetes, affecting pancreatic beta cells which can lead
      to autoimmunity.
  - reference: PMID:22891485
    supports: PARTIAL
    snippet: Environmental factors must be involved such as viral infections, toxins
      from food, cow milk during childhood (instead of breast feeding) or vitamin
      D deficiency.
    explanation: This reference suggests that viral infections are among several environmental
      factors associated with Type I Diabetes, but does not pinpoint them as the singularly
      most critical factor.
  - reference: PMID:34942009
    supports: SUPPORT
    snippet: Enteroviruses, especially CoxB and Echo, are most represented.
    explanation: This reference supports the role of viral infections in Type I Diabetes,
      mentioning enteroviruses among others.
  - reference: PMID:18357774
    supports: PARTIAL
    snippet: The most often cited environmental agents implicated as initiators of
      T1D are the human enteroviruses, in particular the group B coxsackieviruses
      (CVB).
    explanation: This reference supports the role of enteroviruses as environmental
      triggers for Type I Diabetes but notes that evidence is not firmly established.
  - reference: PMID:24003924
    supports: PARTIAL
    snippet: Enteroviruses are proposed candidate triggers due to temporal correlations
      between infection and T1D autoimmunity and to detection of viral proteins in
      diseased islets.
    explanation: The reference suggests enteroviruses as potential triggers for Type
      I Diabetes but emphasizes the need for more robust evidence for a causative
      relationship.
  - reference: PMID:11334504
    supports: SUPPORT
    snippet: Congenital rubella is the only infection clearly associated with the
      development of type 1A diabetes.
    explanation: This reference specifically mentions congenital rubella as an infection
      clearly associated with Type I Diabetes, supporting the statement.
  - reference: PMID:31401790
    supports: PARTIAL
    snippet: The natural history of human type 1 diabetes (T1D) and the documented
      associations between virus infections (in particular the enteroviruses) and
      disease development.
    explanation: This reference discusses associations between viral infections, particularly
      enteroviruses, and Type I Diabetes development, but indicates a need for further
      studies.
  - reference: PMID:17691946
    supports: SUPPORT
    snippet: evidence from various animal models suggests that viruses can indeed
      initiate or accelerate autoimmune diseases, such as type 1 diabetes...
    explanation: This reference provides evidence from animal models that support
      the initiation or acceleration of Type I Diabetes by viruses.
  - reference: PMID:36950864
    supports: SUPPORT
    snippet: Convincing evidence indicates that viruses are associated with T1D development
      and progression.
    explanation: This reference provides convincing evidence that viral infections,
      including SARS-CoV-2, may trigger or unmask Type I Diabetes.
  exposure_term:
    preferred_term: Viral infection exposure
    term:
      id: ECTO:3000001
      label: exposure to virus
- name: Early Dietary Factors
  notes: Possible risk factors include early exposure to cow&#39;s milk and gluten
  evidence:
  - reference: PMID:8741809
    supports: PARTIAL
    snippet: There is a relationship between early cow&#39;s milk exposure and the development
      of Type 1 diabetes in humans, and between early cow&#39;s milk exposure and the
      development of autoimmune diabetes in rodent models of Type 1 diabetes.
    explanation: The reference supports early dietary factors such as cow&#39;s milk exposure
      but indicates that the data are insufficient to conclude a causal relationship.
  - reference: PMID:26605913
    supports: NO_EVIDENCE
    snippet: Recently, the results of two large randomized trials have shown that
      breastfeeding in general, breastfeeding during gluten introduction, and early
      or delayed gluten introduction do not influence the total risk of CD in genetically
      predisposed individuals.
    explanation: The reference suggests that early or delayed introduction of gluten
      does not influence the risk of celiac disease, type 1 diabetes mellitus, and
      wheat allergy, providing no supporting evidence for early dietary factors as
      risk factors for Type 1 diabetes.
  - reference: PMID:20640941
    supports: PARTIAL
    snippet: Given that type 1 diabetes, and its preclinical autoimmunity, appear
      early in life, infant and childhood diet have been implicated as potential initiating
      exposures in the etiology of the disease.
    explanation: The reference implicates early dietary factors in the risk of Type
      1 diabetes but also highlights inconsistencies and the need for further research.
  - reference: PMID:17203405
    supports: PARTIAL
    snippet: Enteroviruses (especially Coxsackie B virus), breastfeeding, the early
      presence or lack of certain foods, birth weight, childhood over-nutrition, maternal
      islet autoimmunity, and negative stress events have been shown to be related
      to the prevalence of T1D.
    explanation: The reference supports a link between early dietary factors and Type
      1 diabetes but does not provide conclusive evidence.
  exposure_term:
    preferred_term: Early dietary exposure
treatments:
- name: Insulin Therapy
  description: Essential treatment to replace the missing insulin and regulate blood
    glucose levels.
  evidence:
  - reference: PMID:21584767
    supports: SUPPORT
    snippet: Insulin therapy is a vital hormone replacement therapy in type 1 diabetes
      mellitus.
  - reference: PMID:36476434
    supports: SUPPORT
    snippet: The current standard method for type 1 diabetes (T1D) management majorly
      focuses on controlling blood glucose levels with exogeneous insulin administration.
  - reference: PMID:32342453
    supports: SUPPORT
    snippet: T1DM is caused by absolute lack of insulin secretion, so the current
      treatment for T1DM patients is exogenous insulin replacement therapy.
  - reference: PMID:20723814
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference lacks specific details pertaining to treatment.
  - reference: PMID:31426099
    supports: PARTIAL
    snippet: Although a cure for T1D remains the ultimate goal, technology holds the
      promise of keeping youth with T1D in targeted control and minimize the burden
      of this chronic medical condition.
    explanation: The reference acknowledges insulin therapy but focuses more on technological
      advancements rather than confirming insulin therapy as the essential treatment.
  - reference: PMID:28685788
    supports: PARTIAL
    snippet: Replacing C-peptide, a hormone normally co-secreted with insulin, has
      been shown to reduce diabetes-related complications.
    explanation: This reference discusses auxiliary therapy but does not diminish
      the essential role of insulin therapy.
  - reference: PMID:33970586
    supports: SUPPORT
    snippet: The mainstay of management is a regimen of multiple daily injections
      of insulin or continuous subcutaneous insulin delivered via an insulin pump.
  - reference: PMID:15306833
    supports: SUPPORT
    snippet: There is, however, a limit to what can be achieved with existing exogenous
      insulin therapies due to their imperfect pharmacokinetic and pharmacodynamic
      profiles
  - reference: PMID:6749365
    supports: SUPPORT
    snippet: &#39;The results of epidemiological and clinical studies of diabetes in man
      and of studies of experimental diabetes in animals provide strong evidence:
      (1) that insulin-dependent diabetes mellitus is due to absolute or severe deficiency
      of insulin; (2) that replacement treatment with insulin is potentially capable
      of normalizing the metabolic abnormalities; and (3) that normalization of the
      metabolic abnormalities can be expected to prevent or ameliorate the complications
      of the disease&#39;
  - reference: PMID:20666700
    supports: PARTIAL
    snippet: Insulin is the primary medication in the treatment of type 1 diabetes.
      New therapeutic options and prevention strategies (cellular therapies, immunomodulation
      and vaccination) aim to preserve residual beta-cell function.
    explanation: The focus on insulin as primary treatment supports the statement,
      despite mentioning new therapeutic options.
  treatment_term:
    preferred_term: insulin treatment
    term:
      id: MAXO:0000259
      label: insulin treatment
- name: Blood Glucose Monitoring
  description: Regular monitoring to manage glucose levels effectively.
  evidence:
  - reference: PMID:30215903
    supports: SUPPORT
    snippet: There is considerable benefit of tight glucose control in patients with
      type 1 diabetes mellitus. ... Greater frequency of glucose monitoring and continuous
      glucose monitoring are both associated with lower A1C levels.
    explanation: The abstract emphasizes the importance of glucose monitoring in managing
      type 1 diabetes, supporting the statement that regular monitoring is crucial
      for effective glucose level management.
  - reference: PMID:32256447
    supports: SUPPORT
    snippet: Regular self-monitoring of blood glucose levels, and ketones when indicated,
      is an essential component of type 1 diabetes (T1D) management.
    explanation: The abstract reaffirms that regular monitoring of blood glucose is
      essential for managing type 1 diabetes, supporting the statement.
  - reference: PMID:38551884
    supports: SUPPORT
    snippet: Blood glucose monitoring has been an integral part of diabetes treatment
      for many years, whether for type 1 diabetic patients on multiple daily injections
      of insulin, insulin pumps or artificial pancreas, and now for patients with
      type 2 diabetes...
    explanation: The abstract describes blood glucose monitoring as a cornerstone
      in diabetes treatment, which includes the management of type 1 diabetes, thus
      supporting the statement.
  - reference: PMID:11149158
    supports: SUPPORT
    snippet: Sick-day management requires increased monitoring of blood glucose and
      assessment for ketosis.
    explanation: The abstract highlights that during illness, increased blood glucose
      monitoring is necessary for managing type 1 diabetes, further supporting the
      statement about regular monitoring.
- name: Lifestyle Modifications
  description: Maintaining a balanced diet, regular physical activity, and adherence
    to treatment plans.
  evidence:
  - reference: PMID:9314011
    supports: SUPPORT
    snippet: Nutrition therapy and physical activity can assist persons with diabetes
      to achieve metabolic goals. Several lifestyle strategies can be used.
    explanation: The text supports the assertion that maintaining a balanced diet
      and regular physical activity can assist in managing diabetes through lifestyle
      modifications.
  - reference: PMID:16529680
    supports: SUPPORT
    snippet: The patient and physician must work together to optimize glucose control
      involving both insulin administration and caloric intake. Exercise has numerous
      benefits and the type 1 diabetic should take advantage of these benefits.
    explanation: This supports the statement that lifestyle modifications, including
      diet and physical activity, are important in managing type 1 diabetes.
  - reference: PMID:24485215
    supports: SUPPORT
    snippet: Poor lifestyle habits (poor diet quality, sedentary behaviours and smoking)
      are known to be driving factors for increased CMR factors in the general population.
    explanation: The text underlines the significance of maintaining a good lifestyle,
      including a balanced diet and physical activity, as part of diabetes management.
  - reference: PMID:32312302
    supports: SUPPORT
    snippet: Innovative, cost-effective interventions along with beneficial lifestyle
      modifications can improve home-based self-monitoring of blood glucose in T1D
      patients.
    explanation: This reference highlights the role of lifestyle modifications in
      managing type 1 diabetes through controlling blood glucose levels.
  - reference: PMID:37820077
    supports: SUPPORT
    snippet: Weight loss treatments provide a wide-range of benefits in reducing both
      morbidity and mortality in those who are obese.
    explanation: It mentions lifestyle interventions as a part of weight loss treatments
      that benefit T1D management, highlighting their efficacy and safety.
  treatment_term:
    preferred_term: dietary intervention
    term:
      id: MAXO:0000088
      label: dietary intervention
- name: Immunotherapy (Teplizumab)
  description: T-cell-targeting therapy that delays progression from stage 2 to stage 3
    disease by approximately 2-3 years in early-stage patients.
  notes: FDA-approved 2022 for delaying clinical onset in presymptomatic individuals
  evidence:
  - reference: PMID:36877454
    supports: SUPPORT
    snippet: In November 2022, teplizumab was approved in the USA to delay the onset of Stage 3 T1D in adults and pediatric patients 8 years of age and older with Stage 2 T1D
    explanation: This article documents the FDA approval of teplizumab as the first immunotherapy for delaying type 1 diabetes progression.
- name: Continuous Glucose Monitoring
  description: Real-time glucose monitoring systems for improved glycemic control and
    reduced hypoglycemic events.
  notes: Associated with lower HbA1c levels and improved time in range
  evidence:
  - reference: PMID:34872983
    supports: SUPPORT
    snippet: After CGM introduction, the odds ratio (OR) of achieving the HbA1c target of &lt;7.0% improved at 12 months (OR 2.5, P &lt; 0.001) and was maintained at 24 months
    explanation: This population-based study demonstrates that continuous glucose monitoring significantly improves glycemic control with sustained improvements in HbA1c target achievement.
review_notes: Type 1 diabetes is an immune-mediated disease in which autoreactive CD8+ and
  CD4+ T cells destroy insulin-producing pancreatic beta cells, leading to absolute insulin
  deficiency. Interferon signaling (type I and II) plays a central role in beta-cell intrinsic
  responses, upregulating antigen presentation and chemokine production while downregulating
  oxidative phosphorylation. The disease is dominated by HLA class II genetic risk, with
  additional non-HLA loci (INS, PTPN22, IL2RA, CTLA4, TYK2, IFIH1, BACH2) contributing to
  immune regulation and beta-cell susceptibility. The natural history spans three stages from
  silent autoimmunity (stage 1) through dysglycemia (stage 2) to symptomatic hyperglycemia
  (stage 3). Teplizumab, a T-cell-targeting immunotherapy approved in 2022, can delay progression
  by approximately 2-3 years in early-stage disease.
disease_term:
  preferred_term: type 1 diabetes mellitus
  term:
    id: MONDO:0005147
    label: type 1 diabetes mellitus
classifications:
  harrisons_chapter:
    - classification_value: endocrine system disorder
    - classification_value: diabetes mellitus
    - classification_value: autoimmune disease
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Type_I_Diabetes.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>